ALKEM LABS LTD FDA Approval ANDA 213911

ANDA 213911

ALKEM LABS LTD

FDA Drug Application

Application #213911

Application Sponsors

ANDA 213911ALKEM LABS LTD

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002
None (Tentative Approval)003

Application Products

001CAPSULE;ORAL100MG0DROXIDOPADROXIDOPA
002CAPSULE;ORAL200MG0DROXIDOPADROXIDOPA
003CAPSULE;ORAL300MG0DROXIDOPADROXIDOPA

FDA Submissions

UNKNOWN; ORIG1TA2020-12-01STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

ALKEM LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213911
            [companyName] => ALKEM LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"DROXIDOPA","activeIngredients":"DROXIDOPA","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/01\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-12-01
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.